It was reported that RPL19 plays an important role in the progression of hepatocellular carcinoma (Rao et al., 2021), lung adenocarcinoma (Wei et al., 2023) and breast cancer (Hong et al., 2014). The gene discussed is RPL19; the disease is breast cancer.